| Literature DB >> 35399361 |
Mohammad Izadi1, Sae Franklin2, Marianna Bellafiore1, David W Franklin3,4,5.
Abstract
Learning new movement patterns is a normal part of daily life, but of critical importance in both sport and rehabilitation. A major question is how different sensory signals are integrated together to give rise to motor adaptation and learning. More specifically, there is growing evidence that pain can give rise to alterations in the learning process. Despite a number of studies investigating the role of pain on the learning process, there is still no systematic review to summarize and critically assess investigations regarding this topic in the literature. Here in this systematic review, we summarize and critically evaluate studies that examined the influence of experimental pain on motor learning. Seventeen studies that exclusively assessed the effect of experimental pain models on motor learning among healthy human individuals were included for this systematic review, carried out based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement. The results of the review revealed there is no consensus regarding the effect of pain on the skill learning acquisition and retention. However, several studies demonstrated that participants who experienced pain continued to express a changed motor strategy to perform a motor task even 1 week after training under the pain condition. The results highlight a need for further studies in this area of research, and specifically to investigate whether pain has different effects on motor learning depending on the type of motor task.Entities:
Keywords: adaptation; exercise; motor learning; pain; rehabilitation
Year: 2022 PMID: 35399361 PMCID: PMC8987932 DOI: 10.3389/fnhum.2022.863741
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
FIGURE 1Flowchart of study selection process.
Study characteristics.
| References | Participants | Pain characteristics | Testing procedure | Outcome measures | Main results |
|
| Healthy ( | Capsaicin gel to the outer side of the elbow 5 cm (local pain); capsaicin gel to the upper part of the knee joint (remote pain); severity of pain was 7-measuring by VAS | Dart-throwing skill during acquisition (with pain) and retention (without pain) (1 h, 24 h, and 1 week) phases | Coordination variability pattern during throwing in both acquisition and retention phases (maximum wrist flexion range, maximum elbow extension range, shoulder angular displacement range, angular throw velocity, and throw duration) | No sig effect of pain on dart-throwing learning |
|
| Healthy ( | Thermode 3 cm × 3 cm (heat pain) before acquisition phase to the dorsal part of the left wrist (local pain) and the external part of the left leg below the knee joint (remote pain); severity of pain was measured-measuring by NPRS | Finger-tapping task (reproducing the sequence 4-1-3-2-4) during 30 s | Error rate and speed of tapping sequences during baseline, post-immediate, post-60 min, and post-24 h (retention) | No sig effect of tonic pain on the acquisition and retention of finger-tapping task |
|
| Healthy ( | Capsaicin gel around the ankle prior to acquisition phase; severity of pain was moderate-measuring by NPRS | Walking task in the presence of a force field adaptation paradigm in 2 days [acquisition (baseline 1, baseline 2, adaptation, and wash-out) and retention (baseline, adaptation, and wash-out)] | A movement error signal that was made based on the ankle angular displacement | Sig effect of tonic pain on the retention phase of a locomotor task, while no sig change in the acquisition phase of gait |
|
| Healthy ( | Capsaicin gel around the ankle between baseline 1 and baseline 2 in the first day and prior to baseline in the second day; severity of pain was 5.6 ± 0.7 in Day 1 and 5.5 ± 0.7 in Day 2-measuring by NPRS | Walking task in the presence of a force field adaptation paradigm in 2 days [acquisition (baseline 1, baseline 2, adaptation, and wash-out) and retention (baseline, adaptation, and wash-out)] | A mean absolute error, which was created based on the ankle kinematics, and tibialis anterior ratios that showed TA muscle activation in the adaptation phase relative to baseline | No sig effect of cutaneous pain on total motor performance during both acquisition and retention phases |
|
| Healthy ( | Hypertonic saline to the tibialis anterior muscle prior to baseline 1 in the first day; the intensity of pain was 5.3 ± 1.2 out of 10-measuring by NPRS | Walking task in the presence of a force field adaptation paradigm in 2 days [acquisition (baseline 1, baseline 2, adaptation, and wash-out) and retention (baseline, adaptation, and wash-out)] | A mean absolute error, which was created based on the ankle kinematics; relative timing of ankle error; tibialis anterior ratios that showed TA muscle activation in the adaptation phase relative to baseline | No sig effect of muscle pain on total motor performance during both acquisition and retention phases |
|
| Healthy ( | Capsaicin gel for pain group and topical cream for the control group in the lateral part of the right elbow; pain intensity average was above 4-measuring by NPRS | Tracing sequences of sinusoidal pattern waves with various amplitudes and frequencies using the thumb in four phases [pre-acquisition, acquisition, post-acquisition, and retention (24–48 h later)] | Motor error which showed the average distance of subjects’ effort trace from the displayed sinusoidal wave | An improvement in motor learning in response to cutaneous pain |
|
| Healthy ( | Capsaicin gel for pain group and topical cream for control group, remote pain and control pain in the lateral part of the dominant elbow and local pain in the Abductor Pollicis Brevis muscle area; pain intensity average was approximately six during post-motor learning-measuring by NRPS | A repetitive typing task | Response time and accuracy during a typing task at the begging and end of the motor acquisition and 48 h later (motor learning retention) | An improvement in motor learning retention in the presence of local pain; improved motor performance in the baseline in the presence of acute pain |
|
| Healthy ( | Capsaicin gel for pain group in which remote and contralateral pain in the lateral part of the dominant and non-dominant elbow, respectively; local pain in the Abductor Pollicis Brevis muscle area; pain intensity average was evaluated-measuring by NPRS | Tracing sequences of sinusoidal pattern waves with various amplitudes and frequencies using thumb in four phases [pre-acquisition, acquisition, post-acquisition, and retention (24–48 h later)] | Motor error which showed the average distance of subjects’ effort trace from the displayed sinusoidal wave | No sig effect of pain location on motor learning acquisition and retention |
|
| Healthy ( | Capsaicin gel for pain group and topical cream for control group in the lateral part of the dominant elbow; pain intensity average was above 4-measuring by NPRS | Tracing sequences of sinusoidal pattern waves with various amplitudes and frequencies using the thumb in four phases [pre-acquisition, acquisition, post-acquisition, and retention (24–48 h later)] | Mean motor error which showed the average distance of subjects’ effort trace from the displayed sinusoidal wave | An improvement in motor performance in the presence of tonic pain |
|
| Healthy ( | Capsaicin gel for pain group above the elbow between two baseline in the first day; pain intensity average was 7.8 ± 0.9 at the initiation of baseline 2-measuring by NPRS | A reaching task in the presence of force field adaptation in four phases [baseline 1, baseline 2, acquisition, and retention (24 h)] | Final error and the initial range of deviation | No sig effect of tonic pain on baseline reaching performance; a larger final error in the pain group than the control group during both acquisition and retention |
|
| Healthy ( | Capsaicin gel for pain group around the lateral part of the first metacarpal after the first TMS baseline measurement; pain intensity average was above four at the training blocks-measuring by NPRS | A modified version of the sequential visual isometric pinch task in three phases (baseline 1, baseline 2, and acquisition) | Movement time, accuracy, and a skill measure | No sig effect of cutaneous pain on motor skill acquisition |
|
| Healthy ( | Capsaicin gel for pain group and topical cream for control group in the lateral part of the right elbow; pain intensity average was 5 in the post-application phase-measuring by NPRS | A repetitive typing task applying the middle three fingers | Motor training accuracy; reaction time | An improvement in motor performance in the presence of tonic pain |
|
| Healthy ( | Hypertonic saline for pain group; remote pain in the infrapatellar fat pad of the knee and local pain in the FDI; pain intensity average was 0.2 ± 0.4 (vehicle control), 1.7 ± 1 (FDI pain), and 2.1 ± 1.6 (remote pain)-measuring by NRS | A quick movements of finger (the right index finger) adduction | Training performance based on peak acceleration of index finger movement | No sig effect of pain on motor performance |
|
| Healthy ( | Hypertonic saline to the anterior deltoid muscle prior to baseline 2 and before the force field 1 in the first day; the intensity of pain was 4.2 ± 0.3 (out of 10) in the first injection and 3 ± 0.4 in the second injection-measuring by NPRS | A reaching task in the presence of force field adaptation in six phases (baseline 1, baseline 2, force field 1, force field 2, washout 1, force field 2, and washout 2) | Movement accuracy based on the peak perpendicular error and the peak hand velocity; muscle activity of anterior and posterior deltoid, biceps brachii, triceps brachii, and pectoralis major | No sig effect of pain on the final performance; experimental pain group used different strategies to perform the same task compared to the control group |
|
| Healthy ( | Capsaicin gel for pain group and vehicle cream for the control group to the tongue; pain intensity average was between 4 and 6 during the task-measuring by VAS | A tongue-protrusion task | A performance score based on the time that participants kept the cursor within the target box | A sig and negative effect of pain on the overall performance score |
|
| Healthy ( | Capsaicin and lidocaine gels for pain groups and vehicle cream for the control group to the dorsum of the tongue before the first task; pain intensity was maintained above 4-measuring by NRS | A tongue-protrusion task | (Overall, a tongue-task trial, initial, within-session gains) motor performance | A sig decrease in motor performance in the pain groups than the control group |
|
| Healthy ( | Hypertonic saline to the infrapatellar fat pad, distal vastus medialis, proximal vastus medialis, and vastus lateralis; the intensity of pain was approximately three in four different pain locations-measuring by NRS | Isometric knee extension contraction | Muscle activation of VMO, VL, and RF; isometric knee extension force | A sig alteration in both muscle activation and knee extension force in response to different locations of pain |
f, female; yrs, years; VMO, vastus medialis oblique; VL, vastus lateralis; RF, rectus femoris; sig, significant; VAS, visual analog scale; NRS, numerical rating scale; TMS, transcranial magnetic stimulation; FDI, first dorsal interosseus.
Quality assessment of the included studies.
| References | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | Total |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | U | U | 1 | 1 | 1 | U | 1 | U | 1 | 1 | U | 0 | U | 0 | 14 |
|
| 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | U | U | 1 | 1 | 1 | U | 1 | U | 1 | 1 | U | 0 | U | 0 | 15 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | U | U | 0 | U | U | 1 | 1 | 1 | U | 1 | U | 1 | 1 | U | 0 | U | 0 | 15 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | U | U | 0 | U | U | 1 | 1 | 1 | U | 1 | 1 | 1 | 1 | U | 0 | U | 0 | 16 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | U | U | 1 | 0 | 1 | U | 1 | 0 | 0 | U | U | 0 | U | 0 | 11 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | 1 | U | 1 | 1 | 1 | U | 1 | 1 | 1 | U | U | 0 | U | 0 | 15 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | 1 | U | 1 | 1 | 1 | U | 1 | 1 | 1 | U | U | 0 | U | 0 | 15 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | U | U | 1 | 1 | 1 | U | 1 | 1 | 1 | 1 | U | 0 | U | 1 | 16 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | U | U | 0 | 1 | U | 1 | 1 | 1 | U | 1 | 1 | 1 | 1 | U | 0 | U | 0 | 15 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | U | U | 0 | U | U | 1 | 1 | 1 | U | 1 | U | 1 | U | U | 0 | U | 0 | 14 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | U | U | 1 | 1 | 1 | U | 1 | U | 1 | 1 | U | 0 | U | 0 | 14 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | 1 | U | 1 | 1 | 1 | U | 1 | 1 | 1 | 1 | U | 0 | U | 0 | 16 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | U | U | 0 | U | U | 1 | 1 | 1 | U | 1 | U | 1 | 1 | U | 0 | U | 0 | 15 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | 1 | U | 1 | 1 | 1 | U | 1 | 0 | 1 | 1 | U | 0 | 1 | 0 | 16 |
|
| 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | 1 | U | 1 | U | 1 | U | 1 | U | U | 1 | U | 0 | U | 0 | 12 |
|
| 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | 1 | U | 1 | 1 | 1 | U | 1 | 0 | 0 | 1 | U | 0 | U | 0 | 15 |
|
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | U | U | 0 | 1 | U | 1 | U | 1 | U | 1 | 0 | U | 1 | U | 0 | U | 0 | 13 |
U, unable to determine; 1, yes; 0, no. For item 5: 0, no; 1, partially; 2, yes.
Downs and Black checklist items: Reporting [(1) Is the hypothesis/aim/objective of the study clearly described?; (2) Are the main outcomes to be measured clearly described in the Introduction or Methods section?; (3) Are the characteristics of the patients included in the study clearly described?; (4) Are the interventions of interest clearly described?; (5) Are the distributions of principal confounders in each group of subjects to be compared clearly described?; (6) Are the main findings of the study clearly described?; (7) Does the study provide estimates of the random variability in the data for the main outcomes?; (8) Have all important adverse events that may be a consequence of the intervention been reported?; (9) Have the characteristics of patients lost to follow-up been described?; (10) Have actual probability values been reported (e.g., 0.035 rather than <0.05) for the main outcomes except where the probability value is less than 0.001?]; External validity [(11) Were the subjects asked to participate in the study representative of the entire population from which they were recruited?; (12) Were those subjects who were prepared to participate representative of the entire population from which they were recruited?; (13) Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive?]; Internal validity – bias [(14) Was an attempt made to blind study subjects to the intervention they have received?; (15) Was an attempt made to blind those measuring the main outcomes of the intervention?; (16) If any of the results of the study were based on “data dredging,” was this made clear?; (17) In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case-control studies, is the time period between the intervention and outcome the same for cases and controls?; (18) Were the statistical tests used to assess the main outcomes appropriate?; (19) Was compliance with the intervention/s reliable?; (20) Were the main outcome measures used accurate (valid and reliable)?]; Internal validity – confounding (selection bias) [(21) Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited from the same population?; (22) Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited over the same period of time?; (23) Were study subjects randomized to intervention groups?; (24) Was the randomized intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable?; (25) Was there adequate adjustment for confounding in the analyses from which the main findings were drawn?; (26) Were losses of patients to follow-up taken into account?]; (27) Power: Did the study have sufficient power to detect a clinically important effect where the probability value for a difference being due to chance is less than 5%?
Synthesized results of the included studies.
| References | Type of pain | Motor performance | Motor strategies |
|
| Cutaneous pain | No change in acquisition and retention phases | Change in coordination patterns |
|
| Cutaneous pain | No change in acquisition and retention phases | No report |
|
| Cutaneous pain | No change in acquisition but a decrease in retention phase | No report |
|
| Cutaneous pain | No change in acquisition and retention phases | Change in a pattern of kinematic errors |
|
| Muscle pain | No change in acquisition and retention phases | Change in feedforward strategies |
|
| Cutaneous pain | An increase in acquisition and no change in retention phases | No report |
|
| Cutaneous pain | An increase in acquisition and retention phases | No report |
|
| Cutaneous pain | No change in acquisition and retention phases regarding pain location (local pain vs. remote pain) | No report |
|
| Cutaneous pain | An increase in acquisition and retention phases | No report |
|
| Cutaneous pain | A decrease in acquisition and retention phases | larger final error to perform a reaching task |
|
| Cutaneous pain | No change in the acquisition phase | No report |
|
| Cutaneous pain | An increase in the acquisition phase | No report |
|
| Muscle pain | No change | No report |
|
| Muscle pain | No change | Change even after the resolution of pain |
|
| Tongue pain | A decrease in total performance | No report |
|
| Tongue pain | A decrease in total performance | No report |
|
| Muscle pain | Change in total performance | Change in muscle activation pattern |